TBPH logo

TBPH EV/EBITDA

Current (TTM)10.24×
TBPH Quarterly EV/EBITDA (0.00× → 830.92×)
High-resolution chart · PNG

TBPH ev/ebitda history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Theravance Biopharma Inc EV/EBITDA — Quarterly
Period endingEV/EBITDA
830.9201×
-109.5752×
11.435×
-361.556×
4.2513×
-30.6531×
-62.6223×
-48.9662×
-35.2985×
-50.0423×
-109.0808×
-76.49×
-37.9718×
-24.4348×
-43.6893×
-33.4779×
-70.4721×
-48.8388×
-39.3441×
-22.2252×
-37.1329×
-22.9734×
-22.9194×
-25.1919×
-38.0631×
-24.0237×
-33.7672×
-27.4458×
-41.4924×
-24.8097×
-30.3505×
-33.6005×
-30.0036×
-22.4476×
-20.9741×
-30.7293×
-34.5252×
-34.4442×
-25.4039×
-49.3681×
-18.2648×
-14.4524×
-8.8276×
-5.7375×
-7.5953×
-12.6161×
-5.9252×
-12.4462×
-13.2911×
-12.2785×
-16.7974×
-17.9851×
-19.0676×
-23.5357×
-25.625×
0×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.